New Drug Candidate Receives FDA Orphan Drug Status for Pancreatic Cancer
Canget BioTekpharma LLC has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for their drug candidate, FL118, as a potential …
Unleashing Industry Insights, Connecting the Future
Canget BioTekpharma LLC has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for their drug candidate, FL118, as a potential …
Pancreatic cancer is one of the deadliest cancers with a low survival rate. However, ongoing research and developments in therapeutics and diagnostics promise better outcomes …
The Pancreatic Cancer Therapeutics And Diagnostic Market is estimated to be valued at US$ 4255.87 Mn in 2023 and is expected to exhibit a CAGR …